SCHEMBL20093337

SCHEMBL20093337

CCN1CCCC[C@H]1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2118584 1.00
Trimethylammonium SCHEMBL27467322 0.94 ALDH1A1 (0.33)
SCHEMBL21870597 0.93
SCHEMBL3401259 0.93
Bicarbonate SCHEMBL28006850 0.90 ALDH1A1 (0.38)
SCHEMBL10866756 0.82
SCHEMBL11654259 0.82 LMNA (0.38)
Ammonia Solution, Strong SCHEMBL28696146 0.80 LMNA (0.37)
SCHEMBL27552046 0.79 S1PR1 (0.41)
SCHEMBL17517004 0.77 S1PR1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266330-A1 COMPOUNDS THAT SYNERGIZE WITH COPPER TO KILL STREPTOCOCCUS PNEUMONIAE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2022-12-22 WO disclosed
US-10695346-B2 4,6-pyrimidinylene derivatives and uses thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-06-30 US disclosed
US-20180110778-A1 4,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-04-26 US disclosed